Refine your search
217 trials found
All(217)
Recruiting(184)
Not yet recruiting(33)
Recruiting
NCT05543616
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
SARS-CoV-2 Virus, Severe Acute Respiratory Syndrome Coronavirus 2, COVID-19
Male or Female
6 months - 11 years
83study location(s)
Recruiting
NCT05355701
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma
Male or Female
16+ years
80study location(s)
Recruiting
NCT05509400
Efficacy and Tolerability of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use
Migraine
Male or Female
18+ years
214study location(s)
Recruiting
NCT05492500
A Study of Ponsegromab in People With Heart Failure
Heart Failure
Male or Female
18+ years
270study location(s)
Recruiting
NCT05317416
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
Multiple Myeloma
Male or Female
18+ years
360study location(s)
Recruiting
NCT05675449
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
Multiple Myeloma
Male or Female
18+ years
52study location(s)
Recruiting
NCT05518123
Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With History of Inadequate Response to Oral Preventive Medications
Migraine
Male or Female
18+ years
260study location(s)
Recruiting
NCT06072183
A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2
Stable Nonsegmental Vitiligo, Active Nonsegmental Vitiligo
Male or Female
18+ years
160study location(s)
Recruiting
NCT04624230
Evaluation of Oral Tofacitinib in Children Aged 2 to 17 Years Old Suffering From Moderate to Severe Ulcerative Colitis
Ulcerative Colitis
Male or Female
2 - 17 years
194study location(s)
Recruiting
NCT06152575
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
Multiple Myeloma
Male or Female
18+ years
6study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
All(217)
Recruiting(184)
Not yet recruiting(33)
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.